Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Alopecia in young women improves with effective treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

COVID-19 can harm many body parts, not just the lungs.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Neurosteroids show promise for treating epilepsy and more research is needed.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.